Levitex Foams Ltd 10333239 Medical and Orthopaedic Product Developement false 1 September 2024 10333239 2024-09-01 2025-08-31 10333239 2024-08-31 10333239 2025-08-31 10333239 2023-09-01 2024-08-31 10333239 2023-08-31 10333239 2024-08-31 10333239 frs102-bus:FRS102 2024-09-01 2025-08-31 10333239 frs102-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 10333239 frs102-bus:FullAccounts 2024-09-01 2025-08-31 10333239 frs102-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 10333239 frs102-core:CurrentFinancialInstruments 2025-08-31 10333239 frs102-core:CurrentFinancialInstruments 2024-08-31 10333239 frs102-core:Non-currentFinancialInstruments 2025-08-31 10333239 frs102-core:Non-currentFinancialInstruments 2024-08-31 10333239 frs102-core:ShareCapital 2025-08-31 10333239 frs102-core:ShareCapital 2024-08-31 10333239 frs102-core:RetainedEarningsAccumulatedLosses 2025-08-31 10333239 frs102-core:RetainedEarningsAccumulatedLosses 2024-08-31 10333239 frs102-bus:Director1 2024-09-01 2025-08-31 10333239 frs102-core:Non-currentFinancialInstruments 2024-08-31 10333239 frs102-bus:OrdinaryShareClass1 2025-08-31 10333239 frs102-bus:OrdinaryShareClass1 2024-08-31 10333239 frs102-bus:OrdinaryShareClass1 2024-09-01 2025-08-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares

| Registered number
| 10333239

| Levitex Foams Ltd |
| Unaudited Accounts |
| for the year ended |
| 31 August 2025 |

Levitex Foams Ltd Balance Sheet as at 31 August 2025
| Notes |  | 2025 £ |  | 2024 £
--- | --- | --- | --- | --- | ---
Fixed assets |  |  |  |  |
Investments | 4 |  | 65,000 |  | 65,000
|  |  | 65,000 |  | 65,000
Current assets |  |  |  |  |
Stocks |  | 149,176 |  | 420,212 |
Debtors |  | 0 |  | 94,911 |
Cash at bank and in hand |  | 140 |  | 967 |
|  | 149,316 |  | 516,090 |
Creditors: amounts falling due within one year | 5 | (639,148) |  | (71,451) |
Net current assets / (liabilities) |  |  | (489,832) |  | 444,639
Total assets less current liabilities |  |  | (424,832) |  | 509,639
Creditors: amounts falling due after more than one year |  |  | (0) |  | (26,643)
Provisions for liabilities |  |  | (0) |  | (0)
Accruals and deferred income |  |  | (19,051) |  | (7,223)
Total net assets (liabilities) |  |  | (443,883) |  | 475,773
Capital and reserves |  |  |  |  |
Called up share capital | 6 |  | 1,737,267 |  | 1,737,267
Profit and loss account |  |  | (2,181,150) |  | (1,261,494)
Shareholders' funds |  |  | (443,883) |  | 475,773

Levitex Foams Ltd
Balance Sheet
as at 31 August 2025

These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Mr J Leinhardt

Director

Approved by the board on 26 May 2026

Company Number: 10333239 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

193a Ashley Road
Hale
Altrincham
Cheshire
WA15 9SQ
United Kingdom

Levitex Foams Ltd
Notes to the Accounts
for the year ended 31 August 2025

1. | Accounting policies
--- | ---
| Basis of preparation of financial statements These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.

2. | Employees
--- | ---
|  | 2025 |  | 2024
| Average number of employees during the period | 10 |  | 9

3. | Intangible fixed assets
--- | ---
|  | Total
| Cost | £
| At 1 September 2024 | 21,023
| At 31 August 2025 | 21,023
| Amortisation |
| At 1 September 2024 | 21,023
| At 31 August 2025 | 21,023
| Net book value |
| At 31 August 2025 | 0
| At 31 August 2024 | 0

4. | Investments
--- | ---
|  | Shares in subsidiary undertakings |  | Total
|  | £ |  | £
| Carrying amount at 1 September 2024 | 65,000 |  | 65,000
| Carrying amount at 31 August 2025 | 65,000 |  | 65,000

5. | Creditors: amounts falling due within one year
--- | ---
|  | 2025 |  | 2024
|  | £ |  | £
| Bank Loans & Overdrafts | 317,767 |  | 9,998
| Trade creditors | 0 |  | 40,845
| Taxation & social security | 285,122 |  | 20,608
| Other creditors | 36,259 |  | 0
|  | 639,148 |  | 71,451

6. | Share capital
--- | ---
|  | 2025 |  | 2024
|  | £ |  | £
| Allotted, called up and fully paid: |  |  |
| 300,000 (2024: 300,000) Ordinary shares of £2.91 each | 873,000 |  | 873,000
|  | 1,737,267 |  | 1,737,267